FIELD: pharmaceutical industry and gastroenterology. SUBSTANCE: new pharmaceutical composition is prepared by combining substance raising gastric pH value and acid- degradable antibacterial substance, e.g. benzylpenicillin, erythromycin, clarithromycin. Histamine H2-receptor blockers are proposed as gastric juice secretion inhibitors. EFFECT: increased biological availability of antibiotic in treatment of ulcer of stomach and peptic ulcer. 16 cl, 8 tbl, 3 ex
| Title |
Year |
Author |
Number |
| REGIME OF ADMINISTRATION OF INHIBITORS OF [H,K]-ATPASE |
1997 |
- Sederberg Krister
- Sehchs Dzhordzh
|
RU2203662C2 |
| NOVEL COMPOUNDS |
1997 |
- Amin Kosrat
- Dakhl'Strem Mikaehl'
- Nordberg Peter
- Starke Ingemar
|
RU2184113C2 |
| CONTAINER OF MEDICINAL AGENTS FOR TREATMENT AND PROPHYLAXIS OF GASTROENTERIC DISEASES CAUSED OR MEDIATED BY INFECTION WITH HELICOBACTER PYLORI |
2002 |
|
RU2214819C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI |
2014 |
- Fatkhi Reza
- Radaj Gilead
- Goldberg Gaj
- Gosselen Patrik
|
RU2671400C2 |
| PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION TO ANIMALS, METHOD OF ITS PREPARING AND METHOD OF TREATMENT OF DISEASES ASSOCIATED WITH ACID SECRETION IN STOMACH |
1994 |
- Stig-Jeran Artur Olovson
- Oke Gunnar Pil'Brant
|
RU2131267C1 |
| METHOD OF PREPARING PHARMACEUTICAL MEDICINAL FORM, METHOD OF INHIBITION OF ACID SECRETION IN STOMACH OF MAMMALS AND HUMANS |
1996 |
- Lundberg Per Jokhan
- Levgren Kurt
|
RU2170090C2 |
| PHARMACEUTICAL COMPOSITION WITH ENTEROSOLUBLE COATING, METHOD OF ITS PREPARING, METHOD OF TREATMENT OF PATIENTS |
1994 |
- Inga Siv Vengtsson
- Kurt Ingmar Levgren
|
RU2138254C1 |
| ANTIGEN OF HELICOBACTER PYLORI AND VACCINE COMPOSITION |
1996 |
- Belin Ingrid
- Svennerkhol'M Ann-Mari
|
RU2195463C2 |
| OMEPRAZOLE MAGNESIUM SALT, METHOD OF ITS PREPARING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1994 |
- Lars Oke Kel'Strem
- Monika Annelie Njugren
|
RU2139868C1 |
| OPTICALLY PURE Na, Mg, Li, K OR Ca SALTS OF (-)-5-METHOXY-2-[[(4- -METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZ-IMIDAZOLE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID AND INTERMEDIATE COMPOUND |
1994 |
- Per Lennart Lindberg
- Sverker Von Unge
|
RU2137766C1 |
